GENESIS Biomed sponsors the ITEMAS 2021 Annual Conference

by GENESIS Biomed

The conference brought together more than 150 specialists from the 60 hospitals that make up ITEMAS to share ideas and discuss the challenges of innovation in the healthcare system, focusing on two im...

Read more

El Ramón y Cajal participa en un proyecto para investigar la Esclerosis Lateral Amiotrófica

by Hospital Universitario Ramón y Cajal

El Servicio de Genética del Hospital Universitario Ramón y Cajal junto con el Laboratorio de Investigación en ELA del Hospital Universitario 12 de Octubre y el Instituto de Investigación CIC nanoG...

Read more

NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders

by Ysios Capital

​NorthSea Therapeutics B.V., (‘NST’) a biotech company developing novel and innovative strategies for the treatment of non-alcoholic steatohepatitis (NASH) and other metabolic diseases, today an...

Read more

What do investors look for when funding a project?

by Biocat

Final session of the second Biocat Pitch Training Program with helpful tips for catching investors’ eyes. Take note and put them into practice!

Read more

La start-up biotecnológica gallega Origo Biopharma ha sido adquirida por el grupo biotecnológico belga Agomab Therapeutics

by Bioga Clúster Tecnológico Empresarial Das Ciencias da Vida

Origo Biopharma, con sede en el Parque Empresarial de Touro (Galicia), es una biotec fundada en 2017 por Julio Castro y GalChimia, dirigida por Ramon Bosser, CEO y accionista de la compañía. La comp...

Read more

Oncoheroes Biosciences Receives A Second Investment From Rally Foundation

by Oncoheroes Biosciences

​ In April 2021, Rally Foundation For Childhood Cancer Research invested for the first time in Oncoheroes Biosciences. Today, we are thrilled to announce that Rally Foundation is investing again ba...

Read more

Sartorius closes fiscal 2021 with 50 percent growth and a jump in profitability

by Sartorius Stedim Spain

Due to the excellent development of its core business, additional demand generated by the coronavirus pandemic, and several acquisitions, the life science group Sartorius closed fiscal 2021 with excep...

Read more

NorthSea Therapeutics, supported by Ysios Capital, Initiates Phase 1 Trial of SEFA-6179, Targeting the Orphan Indication Intestinal Failure-Associated Liver Disease

by Ysios Capital

NorthSea Therapeutics B.V., (‘NST’), a biotech company developing novel and innovative strategies for the treatment of NASH and other metabolic diseases, announces it has initiated a Phase 1 stud...

Read more

Atlas Molecular Pharma closes a EUR 3 million round of funding to advance clinical development of a drug to treat congenital erythropoietic porphyria

by CIC bioGUNE

Atlas Molecular Pharma (Atlas), a spin-off of the CIC bioGUNE research centre - a member of the BRTA - and set up with the aim of developing new pharmacological chaperones for the treatment of rare me...

Read more

SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline

by Ysios Capital

SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced the completion of an oversubscribed €50 million series A financing. The fina...

Read more

Health Tech VC firm Nina Capital, focused on Life Sciences, Closes Oversubscribed Second Fund and Announces its First Four Investments

by Professional Newco

Nina Capital, an emerging specialist venture capital firm, today announced its second fund, started last fall, eclipsed its target size of EUR40 million in just four months. The fund will be used to c...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New advances in cancer viral immunothera...

by Universitat de Barcelona

It has been developed a new strain of vaccinia virus, which can replic...

Photos Stream